BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1652620)

  • 1. Characterization of immune complexes containing cytomegalovirus-specific IgM antibodies following a kidney graft.
    Basson J; Tardy JC; Aymard M
    J Med Virol; 1991 Mar; 33(3):205-10. PubMed ID: 1652620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new C1q solid-phase assay for the detection of IgM immune complexes: application to the follow-up of kidney graft recipients with recurrent cytomegalovirus infection.
    Basson J; Tardy JC; Aymard M
    J Clin Lab Immunol; 1990 Jan; 31(1):43-9. PubMed ID: 1966984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.
    Basson J; Tardy JC; Aymard M
    Arch Virol; 1989; 108(3-4):259-70. PubMed ID: 2557810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
    Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cytomegalovirus-specific IGM in renal transplant recipients.
    McMahon CA; Dock NL; Lentz EB; Forbes BA; Reinitz ER; Lamberson HV
    J Clin Lab Anal; 1989; 3(6):350-4. PubMed ID: 2559178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection.
    Van der Giessen M; van den Berg AP; van der Bij W; Postma S; van Son WJ; The TH
    Clin Exp Immunol; 1990 Apr; 80(1):56-61. PubMed ID: 2157567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus-specific antibody responses in renal transplant patients with primary and recurrent CMV infections.
    O'Neill HJ; Shirodaria PV; Connolly JH; Simpson DI; McGeown MG
    J Med Virol; 1988 Apr; 24(4):461-70. PubMed ID: 2835436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus.
    Kangro HO
    Br J Exp Pathol; 1980 Oct; 61(5):512-20. PubMed ID: 6255978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific IgM class antibody production following infection with cytomegalovirus.
    Kangro HO; Griffiths PD; Huber TJ; Heath RB
    J Med Virol; 1982; 10(3):203-12. PubMed ID: 6296313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients.
    Chou S; Kim DY; Scott KM; Sewell DL
    J Clin Microbiol; 1987 Jan; 25(1):52-5. PubMed ID: 3025251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of antibodies to cytomegalovirus in the sera of renal transplant patients by an IgM antibody capture assay.
    Sutherland S; Briggs JD
    J Med Virol; 1983; 11(2):147-59. PubMed ID: 6302219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
    Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
    Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA).
    Schmitz H; von Deimling U; Flehmig B
    J Gen Virol; 1980 Sep; 50(1):59-68. PubMed ID: 6255087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of specific cytomegalovirus IgM antibodies using infected air dried cells and isolated nuclei by immunoperoxidase assay.
    Singer Y; Kimmel N; Sarov I
    J Virol Methods; 1985 May; 11(1):29-39. PubMed ID: 2989310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection.
    Griffiths PD; Stagno S; Pass RF; Smith RJ; Alford CA
    J Infect Dis; 1982 May; 145(5):647-53. PubMed ID: 6281339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of cytomegalovirus infection in renal allograft recipients. II. Serological response to various viral antigens.
    Gadler H; Sundqvist V; TillegÄrd A; Wahren B
    Scand J Infect Dis; 1982; 14(2):89-94. PubMed ID: 6285452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM antibodies to cytomegalovirus during pregnancy.
    Kampa D; Schmitz H; Doerr HW; Luthardt T; Hillemanns HG; Wurtele A
    Arch Virol; 1977; 53(3):177-84. PubMed ID: 193462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.